by Anderson Triggs | Sep 22, 2026 | Anti-Aging News, Clinical Laboratory Analysis, Sterile & Non-Sterile Compounding, Testosterone & Anti-Aging Therapy
WEBINAR TOMORROW September 23, 2026 1 PM EST / 10 AM PST I am excited to announce my upcoming webinar on peptide therapy, where we will take a practical look at the regulatory landscape, clinical applications, diagnostic considerations, patient selection, monitoring,...
by Anderson Triggs | Jul 23, 2026 | Anti-Aging News, Sterile & Non-Sterile Compounding, Testosterone & Anti-Aging Therapy
Here’s What That Actually Means The conversation around peptides is changing. On July 23 and 24, 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) will meet to review several of the most well-known peptides in regenerative and longevity...
by Anderson Triggs | Mar 19, 2026 | Anti-Aging News, Sterile & Non-Sterile Compounding
The Next Evolution in Regenerative Peptide Therapy When it comes to advanced recovery and regenerative medicine, few compounds have generated as much interest as BPC-157. Known for its powerful effects on muscle, tendon, ligament, and gastrointestinal healing, BPC-157...
by Anderson Triggs | May 4, 2025 | Anti-Aging News, Testosterone & Anti-Aging Therapy
In the constantly evolving landscape of male hormone optimization, few clinical challenges are as delicate as maintaining fertility while undergoing testosterone optimization therapy (TOT). Conventional wisdom and physiology tell us that exogenous testosterone...
by Anderson Triggs | Mar 8, 2025 | Anti-Aging News, Testosterone & Anti-Aging Therapy
The U.S. Food and Drug Administration (FDA) has once again reversed course on a major drug safety issue—this time, on testosterone therapy. In response to findings from the TRAVERSE clinical trial and post market ambulatory blood pressure (ABPM) studies, the FDA is...
